nasdaq:medp
|
https://www.indeed.com/cmp/medpace
|
Aug 29th, 2022 12:00AM
|
Open
|
Medpace
|
|
Pharmaceutical & Biotechnology
|
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries.
|
RRv1_100M_500M
|
5375 Medpace Way Cincinnati, Ohio 45227
|
August Troendle, MD
|
|
|
2.60
|
51.0
|
64.0
|
57.0
|
58.0
|
48.0
|
49.0
|
52.0
|
60.0
|
47.0
|
56.0
|
49.0
|
61.0
|
63.0
|
122.0
|
177.00
|
177.00
|
2.50
|
2.50
|
2.50
|
2.40
|
2.80
|
38.00
|
About two weeks
|
41.00
|
MEDIUM
|
38.00
|
AVERAGE
|
|
|
|
Aug 29th, 2022 12:15PM
|
Aug 29th, 2022 12:15PM
|
Medpace
|
|
|
nasdaq:medp
|
https://www.indeed.com/cmp/medpace
|
Aug 28th, 2022 12:00AM
|
Open
|
Medpace
|
|
Pharmaceutical & Biotechnology
|
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries.
|
RRv1_100M_500M
|
5375 Medpace Way Cincinnati, Ohio 45227
|
August Troendle, MD
|
|
|
2.60
|
51.0
|
64.0
|
57.0
|
58.0
|
48.0
|
49.0
|
52.0
|
60.0
|
47.0
|
56.0
|
49.0
|
61.0
|
63.0
|
122.0
|
177.00
|
177.00
|
2.50
|
2.50
|
2.50
|
2.40
|
2.80
|
38.00
|
About two weeks
|
41.00
|
MEDIUM
|
38.00
|
AVERAGE
|
|
|
|
Aug 28th, 2022 05:15AM
|
Aug 28th, 2022 05:15AM
|
Medpace
|
|
|
nasdaq:medp
|
https://www.indeed.com/cmp/medpace
|
Aug 27th, 2022 12:00AM
|
Open
|
Medpace
|
|
Pharmaceutical & Biotechnology
|
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries.
|
RRv1_100M_500M
|
5375 Medpace Way Cincinnati, Ohio 45227
|
August Troendle, MD
|
|
|
2.60
|
51.0
|
64.0
|
57.0
|
58.0
|
48.0
|
49.0
|
52.0
|
60.0
|
47.0
|
56.0
|
49.0
|
61.0
|
63.0
|
122.0
|
177.00
|
177.00
|
2.50
|
2.50
|
2.50
|
2.40
|
2.80
|
38.00
|
About two weeks
|
41.00
|
MEDIUM
|
38.00
|
AVERAGE
|
|
|
|
Aug 27th, 2022 04:34AM
|
Aug 27th, 2022 04:34AM
|
Medpace
|
|
|
nasdaq:medp
|
https://www.indeed.com/cmp/medpace
|
Aug 25th, 2022 12:00AM
|
Open
|
Medpace
|
|
Pharmaceutical & Biotechnology
|
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries.
|
RRv1_100M_500M
|
5375 Medpace Way Cincinnati, Ohio 45227
|
August Troendle, MD
|
|
|
2.60
|
51.0
|
64.0
|
57.0
|
58.0
|
48.0
|
49.0
|
52.0
|
60.0
|
47.0
|
56.0
|
49.0
|
61.0
|
63.0
|
122.0
|
176.00
|
176.00
|
2.50
|
2.50
|
2.50
|
2.40
|
2.80
|
38.00
|
About two weeks
|
41.00
|
MEDIUM
|
38.00
|
AVERAGE
|
|
|
|
Aug 25th, 2022 09:13AM
|
Aug 25th, 2022 09:13AM
|
Medpace
|
|
|
nasdaq:medp
|
https://www.indeed.com/cmp/medpace
|
Aug 23rd, 2022 12:00AM
|
Open
|
Medpace
|
|
Pharmaceutical & Biotechnology
|
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries.
|
RRv1_100M_500M
|
5375 Medpace Way Cincinnati, Ohio 45227
|
August Troendle, MD
|
|
|
2.60
|
51.0
|
64.0
|
57.0
|
58.0
|
48.0
|
49.0
|
52.0
|
60.0
|
47.0
|
56.0
|
49.0
|
61.0
|
63.0
|
122.0
|
176.00
|
176.00
|
2.50
|
2.50
|
2.50
|
2.40
|
2.80
|
38.00
|
About two weeks
|
41.00
|
MEDIUM
|
38.00
|
AVERAGE
|
|
|
|
Aug 23rd, 2022 11:07AM
|
Aug 23rd, 2022 11:07AM
|
Medpace
|
|
|
nasdaq:medp
|
https://www.indeed.com/cmp/medpace
|
Aug 21st, 2022 12:00AM
|
Open
|
Medpace
|
|
Pharmaceutical & Biotechnology
|
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries.
|
RRv1_100M_500M
|
5375 Medpace Way Cincinnati, Ohio 45227
|
August Troendle, MD
|
|
|
2.60
|
51.0
|
64.0
|
57.0
|
58.0
|
48.0
|
49.0
|
52.0
|
60.0
|
47.0
|
56.0
|
49.0
|
61.0
|
63.0
|
122.0
|
176.00
|
176.00
|
2.50
|
2.50
|
2.50
|
2.40
|
2.80
|
38.00
|
About two weeks
|
41.00
|
MEDIUM
|
38.00
|
AVERAGE
|
|
|
|
Aug 21st, 2022 12:51PM
|
Aug 21st, 2022 12:51PM
|
Medpace
|
|
|
nasdaq:medp
|
https://www.indeed.com/cmp/medpace
|
Aug 20th, 2022 12:00AM
|
Open
|
Medpace
|
|
Pharmaceutical & Biotechnology
|
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries.
|
RRv1_100M_500M
|
5375 Medpace Way Cincinnati, Ohio 45227
|
August Troendle, MD
|
|
|
2.60
|
51.0
|
64.0
|
57.0
|
58.0
|
48.0
|
49.0
|
52.0
|
60.0
|
47.0
|
56.0
|
49.0
|
61.0
|
63.0
|
122.0
|
176.00
|
176.00
|
2.50
|
2.50
|
2.50
|
2.40
|
2.80
|
38.00
|
About two weeks
|
41.00
|
MEDIUM
|
38.00
|
AVERAGE
|
|
|
|
Aug 20th, 2022 02:28PM
|
Aug 20th, 2022 02:28PM
|
Medpace
|
|
|
nasdaq:medp
|
https://www.indeed.com/cmp/medpace
|
Aug 19th, 2022 12:00AM
|
Open
|
Medpace
|
|
Pharmaceutical & Biotechnology
|
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries.
|
RRv1_100M_500M
|
5375 Medpace Way Cincinnati, Ohio 45227
|
August Troendle, MD
|
|
|
2.60
|
51.0
|
64.0
|
57.0
|
58.0
|
48.0
|
49.0
|
52.0
|
60.0
|
47.0
|
56.0
|
49.0
|
61.0
|
63.0
|
122.0
|
176.00
|
176.00
|
2.50
|
2.50
|
2.50
|
2.40
|
2.80
|
38.00
|
About two weeks
|
41.00
|
MEDIUM
|
38.00
|
AVERAGE
|
|
|
|
Aug 19th, 2022 12:50PM
|
Aug 19th, 2022 12:50PM
|
Medpace
|
|
|
nasdaq:medp
|
https://www.indeed.com/cmp/medpace
|
Aug 18th, 2022 12:00AM
|
Open
|
Medpace
|
|
Pharmaceutical & Biotechnology
|
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries.
|
RRv1_100M_500M
|
5375 Medpace Way Cincinnati, Ohio 45227
|
August Troendle, MD
|
|
|
2.60
|
51.0
|
64.0
|
57.0
|
58.0
|
48.0
|
49.0
|
52.0
|
60.0
|
47.0
|
56.0
|
49.0
|
61.0
|
63.0
|
122.0
|
176.00
|
176.00
|
2.50
|
2.50
|
2.50
|
2.40
|
2.80
|
38.00
|
About two weeks
|
41.00
|
MEDIUM
|
38.00
|
AVERAGE
|
|
|
|
Aug 18th, 2022 04:34AM
|
Aug 18th, 2022 04:34AM
|
Medpace
|
|
|
nasdaq:medp
|
https://www.indeed.com/cmp/medpace
|
Aug 17th, 2022 12:00AM
|
Open
|
Medpace
|
|
Pharmaceutical & Biotechnology
|
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries.
|
RRv1_100M_500M
|
5375 Medpace Way Cincinnati, Ohio 45227
|
August Troendle, MD
|
|
|
2.60
|
51.0
|
64.0
|
57.0
|
58.0
|
48.0
|
49.0
|
52.0
|
60.0
|
47.0
|
56.0
|
|
61.0
|
63.0
|
122.0
|
176.00
|
176.00
|
2.50
|
2.50
|
2.50
|
2.40
|
2.80
|
38.00
|
About two weeks
|
41.00
|
MEDIUM
|
38.00
|
AVERAGE
|
|
|
|
Aug 17th, 2022 10:13AM
|
Aug 17th, 2022 10:13AM
|
Medpace
|
|
|